Washington University School of Medicine in St. Louis 7th Annual IBD Center Multidisciplinary Conference 2025

Washington University School of Medicine in St. Louis 7th Annual IBD Center Multidisciplinary Conference 2025

+ Include: 19 Videos (.mp4) + 19 Audios (.mp3) + 19 Subtitles (.vtt) + 14 PDFs, size: 3.82 GB

+ Target Audience: gastroenterologists and multidisciplinary IBD

+ Information:

1. Overview

The Washington University School of Medicine in St. Louis 7th Annual IBD Center Multidisciplinary Conference 2025 provides an advanced clinical review of Inflammatory Bowel Disease (IBD). The program covers the strategic positioning of medical therapies, innovative approaches for refractory disease, multidisciplinary management of complex cases, and the integration of adjunctive dietary and behavioral interventions.

Course Date: Saturday, March 8, 2025

2. Learning Objectives

• Evaluate the optimal positioning of advanced medical therapies, JAK inhibitors, and combination treatments for Crohn’s Disease and Ulcerative Colitis.

• Assess novel approaches for refractory IBD, including the potential role of stem cell transplantation and non-formulary agents.

• Formulate multidisciplinary management plans for complex presentations, such as stricturing disease and acute severe Ulcerative Colitis.

• Integrate adjunctive treatments, including specific dietary protocols, body weight modulation, and mindfulness, into comprehensive IBD care.

• Apply updated clinical guidelines for dysplasia screening, scoping practices, and post-operative recurrence prevention in IBD patients.

3. Target Audienc

Best for gastroenterologists and multidisciplinary IBD teams who want updates on medical therapies, refractory disease, and diet interventions.

4. Topics

1. Positioning Medical Therapies in Crohn’s Disease

2. Debate – Second Line Therapy in Crohns Disease after an Anti-TNF-a – Upadacitinib vs. IL-23

3. Positioning Medical Therapies in Ulcerative Colitis

4. Q&A – Using a JAK inhibitor before anti-TNF, Use of Upadacitinib in France vs. U.S.

5. Novel Approaches to Address Refractory IBD – Stem Cell Transplantation

6. Breaking the Therapeutic Ceiling in IBD through Innovative Trial Designs

7. Q&A – Genetic Testing for Stem Cell Transplantation, Minimizing the Risk of Placebo for Patients Entering Clinical Trials…

8. IBD Case-Based Discussion on Stricturing Disease – Radiologic, Surgical, and Endoscopic Approaches

9. Debate – Role of JAK inhibitors vs. Surgery in the TNFi-exposed Patient with Acute Severe Ulcerative Colitis

10. Q&A – Current Recommendations for Prevention of Recurrence of Crohn’s & UC, Role of MR Enterography is post Cro…

11. Combined Advanced Therapies for IBD – Are We Ready for Prime Time

12. Nutrition as Therapy for Pediatric IBD

13. Diet in Adults with IBD

14. Modulation of Body Weight and Mass as Adjunctive Approaches in IBD Patients

15. Q&A – Will Kids Actually Drink Elemental Formulas, Safety of GLP-1 in Patients with IBD

16. Behavioral Approaches Complimentary with Medical Therapies – Mindfulness and IBD

17. Non-Formulary Agents in Inflammatory Bowel Disease

18. Approach to Dysplasia in IBD

19. Q&A – When Do You Stop Scoping Patients, Efficacy of Tacrolimus Suppositories